Table of contents

Inflammation and inflammatory bowel disease

• Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies (1 December, 2001)

  M S Silverberg, M J Daly, D N Moskovitz, J D Rioux, R S McLeod, Z Cohen, G R Greenberg, T J Hudson, K A Siminovitch, A H Steinhart
• Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease (1 December, 2001)

  E Louis, A Collard, A F Oger, E Degroote, F Aboul Nasr El Yafi, J Belaiche
• Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses (1 December, 2001)

  W Kruis, S Schreiber, D Theuer, J-W Brandes, E Schütz, S Howaldt, B Krakamp, J Hämling, H Mönnikes, I Koop, M Stolte, D Pallant, U Ewald
• A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease (1 December, 2001)

  K Leiper, J Woolner, M M C Mullan, T Parker, M van der Vliet, S Fear, J M Rhodes, J O Hunter
• Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease (1 December, 2001)

  P Middel, K Reich, F Polzien, V Blaschke, B Hemmerlein, J Herms, M Korabiowska, H-J Radzun